TJX elects Vertex CFO Charles F. Wagner Jr. to its Board of Directors

TJX COMPANIES INC /DE/

Charles F. Wagner, Jr., EVP and CFO of Vertex Pharmaceuticals, elected to TJX Board and Audit & Finance Committee effective Sept 20, 2023.
Mr. Wagner receives standard non-employee director compensation including cash retainers and deferred stock awards.
Deferred stock awards under SIP have total target value of $185,000, prorated for election date.
Board determined Mr. Wagner independent per NYSE standards; no prior employment or disclosable transactions.
No arrangements or understandings with any other person regarding his appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Charles F. Wagner, Jr.

Director

TJX · TJX COMPANIES INC /DE/

Effective: 2023-09-20
Filed: September 22, 2023, 7:59 PM ET

On September 20, 2023, the Board of Directors (the “Board”) of The TJX Companies, Inc. (the “Company”) elected Charles F. Wagner, Jr. as a member of the Company’s Board and of its Audit and Finance Committee, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Charles F. Wagner, Jr. was elected as Director at TJX COMPANIES INC /DE/.

Action: elected
Role: Director

Exact text from the filing

On September 20, 2023, the Board of Directors (the “Board”) of The TJX Companies, Inc. (the “Company”) elected Charles F. Wagner, Jr. as a member of the Company’s Board and of its Audit and Finance Committee, effective immediately.

View on SEC.gov

TJX COMPANIES INC /DE/ filing history →

Source: SEC EDGAR

accession 0000109198-23-000055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.